Tirzepatide glycemic control trial in type 2 diabetes
New England Journal of Medicine
2021
Study summary
Tirzepatide compared with existing diabetes therapies.
Peptides studied
Goals studied
Stack studied
Advanced Metabolic Stack
Key findings
Improved glycemic control and body weight reduction observed.
Study details
Study type
randomized clinical trial
Journal
New England Journal of Medicine
DOI / PubMed
10.1056/NEJMoa2107519
Year
2021
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
